These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 28471825)

  • 61. Using insurance claims to predict and improve hospitalizations and biologics use in members with inflammatory bowel diseases.
    Vaughn DA; van Deen WK; Kerr WT; Meyer TR; Bertozzi AL; Hommes DW; Cohen MS
    J Biomed Inform; 2018 May; 81():93-101. PubMed ID: 29625187
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Systematic review: The role of race and socioeconomic factors on IBD healthcare delivery and effectiveness.
    Sewell JL; Velayos FS
    Inflamm Bowel Dis; 2013 Mar; 19(3):627-43. PubMed ID: 22623078
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Residence in Peripheral Regions and Low Socioeconomic Status Are Associated With Worse Outcomes of Inflammatory Bowel Diseases: A Nationwide Study From the epi-IIRN.
    Ledder O; Harel S; Lujan R; Friss C; Orlanski-Meyer E; Yogev D; Loewenberg Weisband Y; Greenfeld S; Kariv R; Lederman N; Matz E; Schwartz D; Focht G; Dotan I; Turner D
    Inflamm Bowel Dis; 2024 Jan; 30(1):1-8. PubMed ID: 36917191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. How to Explain the Dramatic Increase Around 2000 but Recent Leveling Off of Inflammatory Bowel Disease in Korea?
    Qin X
    Inflamm Bowel Dis; 2015 Aug; 21(8):E16-7. PubMed ID: 26111209
    [No Abstract]   [Full Text] [Related]  

  • 65. Association Between Socioeconomic Status and Erectile Dysfunction in Japanese Patients With Ulcerative Colitis: A Cross-Sectional Study.
    Furukawa S; Miyake T; Yoshida O; Shiraishi K; Tange K; Hashimoto Y; Yagi S; Kitahata S; Ninomiya T; Hanayama M; Suzuki S; Shibata N; Murakami H; Ohashi K; Tomida H; Yamamoto Y; Takeshita E; Ikeda Y; Hiasa Y
    Am J Mens Health; 2024; 18(3):15579883241256833. PubMed ID: 38835288
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Childhood Socioeconomic Characteristics and Risk of Inflammatory Bowel Disease: A Scandinavian Birth Cohort Study.
    Sigvardsson I; Størdal K; Östensson M; Guo A; Ludvigsson J; Mårild K
    Inflamm Bowel Dis; 2024 Oct; 30(10):1801-1811. PubMed ID: 37740494
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association between socioeconomic status and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study.
    Kitahata S; Furukawa S; Miyake T; Shiraishi K; Tange K; Hashimoto Y; Yagi S; Ninomiya T; Suzuki S; Shibata N; Murakami H; Ohashi K; Tomida H; Yamamoto Y; Takeshita E; Ikeda Y; Hiasa Y
    BMJ Open Gastroenterol; 2022 Oct; 9(1):. PubMed ID: 36261231
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Health Care Perspectives of Adult Patients with Lower Educational Attainment in Inflammatory Bowel Disease: A Qualitative Study.
    Harvey E; El Bizri M; Nguyen GC; Marshall DA; Mirza R; Sewitch MJ
    J Patient Exp; 2022; 9():23743735221092557. PubMed ID: 35434295
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Gut-Brain Axis and Its Role in Controlling Eating Behavior in Intestinal Inflammation.
    Moran GW; Thapaliya G
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803651
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Impact of Migration on the Gut Metagenome of South Asian Canadians.
    Copeland JK; Chao G; Vanderhout S; Acton E; Wang PW; Benchimol EI; El Sohami A; Croitoru K; Gommerman JL; Guttman DS;
    Gut Microbes; 2021; 13(1):1-29. PubMed ID: 33794735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patient knowledge in inflammatory bowel disease: the Crohn's and Colitis Knowledge Score.
    Wardle RA; Mayberry JF
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):1-5. PubMed ID: 24216568
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its outcomes.
    Wardle RA; Wardle AJ; Charadva C; Ghosh S; Moran GW
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):879-884. PubMed ID: 28471825
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
    Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
    Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study.
    Sulz MC; Siebert U; Arvandi M; Gothe RM; Wurm J; von Känel R; Vavricka SR; Meyenberger C; Sagmeister M;
    Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):790-7. PubMed ID: 23571609
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: a cross-sectional study.
    Carpio D; Barreiro-de Acosta M; Echarri A; Pereira S; Castro J; Ferreiro R; Lorenzo A;
    Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1030-7. PubMed ID: 26049704
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.